Enhancing immune responses to limit chronic immune activation during SIV

Research output: Contribution to journalComment/debate

6 Citations (Scopus)

Abstract

The persistent immune activation that is typical of HIV-1 and SIV infection results in exhaustion and dysfunction of T and B cells; in T cells, this is marked by increased expression and signaling through the inhibitory receptor programmed death-1 (PD-1). Targeting this exhaustion pathway could result in improved antiviral immune responses, but there have been concerns that it would also lead to increased inflammation and immunopathology. In this issue of the JCI, Dyavar Shetty et al. demonstrate that blocking PD-1 actually reduced proinflammatory responses and improved immunity in the gut of SIV-infected rhesus macaques, suggesting that this might have therapeutic potential to prevent opportunistic infections in HIV-infected patients.

Original languageEnglish (US)
Pages (from-to)1611-1614
Number of pages4
JournalJournal of Clinical Investigation
Volume122
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

T-Lymphocytes
Death Domain Receptors
Opportunistic Infections
Macaca mulatta
Antiviral Agents
HIV-1
Immunity
B-Lymphocytes
HIV
Inflammation
Infection
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Enhancing immune responses to limit chronic immune activation during SIV. / Estes, Jacob.

In: Journal of Clinical Investigation, Vol. 122, No. 5, 01.05.2012, p. 1611-1614.

Research output: Contribution to journalComment/debate

@article{c0327317e76a464cb695bb2ae5880c76,
title = "Enhancing immune responses to limit chronic immune activation during SIV",
abstract = "The persistent immune activation that is typical of HIV-1 and SIV infection results in exhaustion and dysfunction of T and B cells; in T cells, this is marked by increased expression and signaling through the inhibitory receptor programmed death-1 (PD-1). Targeting this exhaustion pathway could result in improved antiviral immune responses, but there have been concerns that it would also lead to increased inflammation and immunopathology. In this issue of the JCI, Dyavar Shetty et al. demonstrate that blocking PD-1 actually reduced proinflammatory responses and improved immunity in the gut of SIV-infected rhesus macaques, suggesting that this might have therapeutic potential to prevent opportunistic infections in HIV-infected patients.",
author = "Jacob Estes",
year = "2012",
month = "5",
day = "1",
doi = "10.1172/JCI63389",
language = "English (US)",
volume = "122",
pages = "1611--1614",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Enhancing immune responses to limit chronic immune activation during SIV

AU - Estes, Jacob

PY - 2012/5/1

Y1 - 2012/5/1

N2 - The persistent immune activation that is typical of HIV-1 and SIV infection results in exhaustion and dysfunction of T and B cells; in T cells, this is marked by increased expression and signaling through the inhibitory receptor programmed death-1 (PD-1). Targeting this exhaustion pathway could result in improved antiviral immune responses, but there have been concerns that it would also lead to increased inflammation and immunopathology. In this issue of the JCI, Dyavar Shetty et al. demonstrate that blocking PD-1 actually reduced proinflammatory responses and improved immunity in the gut of SIV-infected rhesus macaques, suggesting that this might have therapeutic potential to prevent opportunistic infections in HIV-infected patients.

AB - The persistent immune activation that is typical of HIV-1 and SIV infection results in exhaustion and dysfunction of T and B cells; in T cells, this is marked by increased expression and signaling through the inhibitory receptor programmed death-1 (PD-1). Targeting this exhaustion pathway could result in improved antiviral immune responses, but there have been concerns that it would also lead to increased inflammation and immunopathology. In this issue of the JCI, Dyavar Shetty et al. demonstrate that blocking PD-1 actually reduced proinflammatory responses and improved immunity in the gut of SIV-infected rhesus macaques, suggesting that this might have therapeutic potential to prevent opportunistic infections in HIV-infected patients.

UR - http://www.scopus.com/inward/record.url?scp=84860557996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860557996&partnerID=8YFLogxK

U2 - 10.1172/JCI63389

DO - 10.1172/JCI63389

M3 - Comment/debate

C2 - 22523060

AN - SCOPUS:84860557996

VL - 122

SP - 1611

EP - 1614

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -